The role of impaired early insulin secretion in the pathogenesis of Type II diabetes mellitus - PubMed (original) (raw)
Review
The role of impaired early insulin secretion in the pathogenesis of Type II diabetes mellitus
R E Pratley et al. Diabetologia. 2001 Aug.
Abstract
Patients with Type II (non-insulin-dependent) diabetes mellitus manifest abnormalities in insulin action and insulin secretion. It is widely accepted that insulin resistance is an early finding, evident before the onset of hyperglycaemia and predictive of the subsequent development of diabetes. Whether abnormalities in insulin secretion also precede and predict diabetes has been debated. However, recent studies clearly indicate that early insulin secretion plays a critical role in maintaining normal glucose homeostasis. Cross-sectional analyses show that acute insulin secretory responses (AIR) to intravenous glucose are lower in subjects with impaired glucose tolerance and those at high risk for developing diabetes. Prospectively, a low AIR predicts the development of diabetes in several populations. In longitudinal studies, AIR declines dramatically as patients progress from normal to impaired glucose tolerance and ultimately to diabetes. Early insulin secretion is important for the rapid and efficient suppression of endogenous glucose production after a meal. Thus, loss of early insulin secretion initially leads to post-prandial hyperglycaemia which, as the disease progresses, worsens to clinical hyperglycaemia. Strategies that enhance early insulin secretion improve glucose tolerance and represent a novel and more physiologic approach to improving glycaemic control in patients with Type II diabetes mellitus.
Similar articles
- Progression from IGT to type 2 diabetes mellitus: the central role of impaired early insulin secretion.
Pratley RE, Weyer C. Pratley RE, et al. Curr Diab Rep. 2002 Jun;2(3):242-8. doi: 10.1007/s11892-002-0090-6. Curr Diab Rep. 2002. PMID: 12643180 Review. - Loss of early insulin secretion leads to postprandial hyperglycaemia.
Del Prato S. Del Prato S. Diabetologia. 2003 Mar;46 Suppl 1:M2-8. doi: 10.1007/s00125-002-0930-6. Epub 2002 Nov 12. Diabetologia. 2003. PMID: 12652352 Review. - [Evaluation of islet beta cell function in subjects with normal glucose tolerance, impaired glucose regulation, and type 2 diabetes mellitus].
Liu J, Li YB, Shao H, Li YX, Yuan YH, Xiao YB, Weng JP. Liu J, et al. Zhonghua Yi Xue Za Zhi. 2007 May 15;87(18):1252-5. Zhonghua Yi Xue Za Zhi. 2007. PMID: 17686259 Chinese. - The importance of first-phase insulin secretion: implications for the therapy of type 2 diabetes mellitus.
Del Prato S, Tiengo A. Del Prato S, et al. Diabetes Metab Res Rev. 2001 May-Jun;17(3):164-74. doi: 10.1002/dmrr.198. Diabetes Metab Res Rev. 2001. PMID: 11424229 Review.
Cited by
- Magnesium from Deep Seawater as a Potentially Effective Natural Product against Insulin Resistance: A Randomized Trial.
Ham JY, Jang YK, Jeon BY, Shon YH. Ham JY, et al. Medicina (Kaunas). 2024 Aug 5;60(8):1265. doi: 10.3390/medicina60081265. Medicina (Kaunas). 2024. PMID: 39202546 Free PMC article. Clinical Trial. - Beta-cell function in type 2 diabetes (T2DM): Can it be preserved or enhanced?
Sayyed Kassem L, Rajpal A, Barreiro MV, Ismail-Beigi F. Sayyed Kassem L, et al. J Diabetes. 2023 Oct;15(10):817-837. doi: 10.1111/1753-0407.13446. Epub 2023 Jul 31. J Diabetes. 2023. PMID: 37522521 Free PMC article. Review. - Elucidating the Potential Inhibitor against Type 2 Diabetes Mellitus Associated Gene of GLUT4.
Aldahish A, Balaji P, Vasudevan R, Kandasamy G, James JP, Prabahar K. Aldahish A, et al. J Pers Med. 2023 Apr 12;13(4):660. doi: 10.3390/jpm13040660. J Pers Med. 2023. PMID: 37109046 Free PMC article. - Can Circadian Eating Pattern Adjustments Reduce Risk or Prevent Development of T2D?
Harris C, Czaja K. Harris C, et al. Nutrients. 2023 Apr 4;15(7):1762. doi: 10.3390/nu15071762. Nutrients. 2023. PMID: 37049602 Free PMC article. Review. - Glucose-lowering effect of berberine on type 2 diabetes: A systematic review and meta-analysis.
Xie W, Su F, Wang G, Peng Z, Xu Y, Zhang Y, Xu N, Hou K, Hu Z, Chen Y, Chen R. Xie W, et al. Front Pharmacol. 2022 Nov 16;13:1015045. doi: 10.3389/fphar.2022.1015045. eCollection 2022. Front Pharmacol. 2022. PMID: 36467075 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical